BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12625243)

  • 1. [Philadelphia chromosome].
    Majsterek I; Błasiak J
    Postepy Biochem; 2002; 48(3):156-66. PubMed ID: 12625243
    [No Abstract]   [Full Text] [Related]  

  • 2. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular biological pathophysiology of chronic myelogenous leukemia].
    Nishimura J
    Fukuoka Igaku Zasshi; 1995 Feb; 86(2):19-23. PubMed ID: 7729779
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leucemogenesis of chronic myelogenous leukemia].
    Mahon FX
    Rev Prat; 2005 Oct; 55(15):1642-6. PubMed ID: 16334200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the 5' abl region in Philadelphia chromosome-positive chronic myeloid leukemia.
    Morel F; Ka C; Le Bris MJ; Herry A; Morice P; Bourquard P; Abgrall JF; Berthou C; De Braekeleer M
    Leukemia; 2003 Feb; 17(2):473-4. PubMed ID: 12592354
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress on the study of related genes in patients with blast crisis of chronic myelocytic leukemia].
    Xiong H; Chen X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):49-51. PubMed ID: 11498844
    [No Abstract]   [Full Text] [Related]  

  • 8. BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.
    Stoklosa T; Poplawski T; Koptyra M; Nieborowska-Skorska M; Basak G; Slupianek A; Rayevskaya M; Seferynska I; Herrera L; Blasiak J; Skorski T
    Cancer Res; 2008 Apr; 68(8):2576-80. PubMed ID: 18413724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 10. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of BCR/ABL fusion proteins on the course of Ph leukemias.
    Telegeev GD; Dubrovska AN; Dybkov MV; Maliuta SS
    Acta Biochim Pol; 2004; 51(3):845-9. PubMed ID: 15448745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ABL fusion gene].
    Yamauchi T; Ueda T
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():41-4. PubMed ID: 23513809
    [No Abstract]   [Full Text] [Related]  

  • 13. BCR-ABL in chronic myelogenous leukemia--how does it work?
    Goldman JM; Melo JV
    Acta Haematol; 2008; 119(4):212-7. PubMed ID: 18566539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
    Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
    Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
    Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
    [No Abstract]   [Full Text] [Related]  

  • 17. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of BCR-ABL.
    Chopra R; Pu QQ; Elefanty AG
    Blood Rev; 1999 Dec; 13(4):211-29. PubMed ID: 10741897
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous occurrence of variant Philadelphia translocations and ABL mutations in two patients with chronic myeloid leukemia.
    Zhao Y; Wu G; Wu K; Liu L; Cao W; Yu X; Luo Y; Shi J; Tan Y; Huang H
    Leuk Res; 2009 Jul; 33(7):e85-7. PubMed ID: 19203793
    [No Abstract]   [Full Text] [Related]  

  • 20. CML resistance to tyrosine kinase inhibitors: how is the laboratory to tell?
    Goldman J
    Lab Hematol; 2004; 10(3):181-4. PubMed ID: 15529444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.